Opens in a new tab or window LOS ANGELES -- For surgeons already split on their preference of inhaled pulmonary vasodilator to prevent postoperative right ventricular (RV) failure, a shifting ...
who continue to deteriorate despite optimal pulmonary vasodilator therapy – including intravenous prostanoids and combination therapy. Identification of poor prognostic markers in PAH ...
Pulmonary vasodilator treatment with the prostacyclin analogue, iloprost and the endothelin receptor antagonist, bosentan, has been reported to improve survival on the transplant waiting list and ...
HPS involves hypoxemia due to pulmonary vasodilation in cirrhotic patients, leading to significant morbidity. The pathophysiology is linked to increased levels of vasodilators and angiogenic factors.